Patent foramen ovale closure in 2019 JP Giblett, O Abdul-Samad, LM Shapiro, BS Rana, PA Calvert Interventional Cardiology Review 14 (1), 34, 2019 | 62 | 2019 |
Functional polymorphism in ABCA1 influences age of symptom onset in coronary artery disease patients T Kyriakou, DE Pontefract, E Viturro, CP Hodgkinson, RC Laxton, ... Human molecular genetics 16 (12), 1412-1422, 2007 | 50 | 2007 |
Patent foramen ovale closure: state of the art JP Giblett, LK Williams, S Kyranis, LM Shapiro, PA Calvert Interventional Cardiology Review 15, 2020 | 40 | 2020 |
Glucagon-like peptide-1: a promising agent for cardioprotection during myocardial ischemia JP Giblett, SJ Clarke, DP Dutka, SP Hoole JACC: Basic to Translational Science 1 (4), 267-276, 2016 | 35 | 2016 |
Direct stenting is an independent predictor of improved survival in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction LM McCormick, AJ Brown, LS Ring, PR Gajendragadkar, SJ Dockrill, ... European Heart Journal: Acute Cardiovascular Care 3 (4), 340-346, 2014 | 35 | 2014 |
Percutaneous management of paravalvular leaks JP Giblett, BS Rana, LM Shapiro, PA Calvert Nature reviews cardiology 16 (5), 275-285, 2019 | 34 | 2019 |
Post-infarction ventricular septal defect: percutaneous or surgical management in the UK national registry JP Giblett, A Matetic, D Jenkins, CY Ng, S Venuraju, T MacCarthy, ... European heart journal 43 (48), 5020-5032, 2022 | 32 | 2022 |
Transcatheter treatment of postinfarct ventricular septal defects JP Giblett, DP Jenkins, PA Calvert Heart 106 (12), 878-884, 2020 | 27 | 2020 |
Optical coherence tomography guided percutaneous coronary intervention FJ Ha, JP Giblett, N Nerlekar, JD Cameron, IT Meredith, NEJ West, ... Heart, Lung and Circulation 26 (12), 1267-1276, 2017 | 18 | 2017 |
Glucagon-like peptide-1 derived cardioprotection does not utilize a KATP-channel dependent pathway: mechanistic insights from human supply and demand ischemia studies JP Giblett, RG Axell, PA White, SJ Clarke, L McCormick, PA Read, ... Cardiovascular diabetology 15, 1-12, 2016 | 18 | 2016 |
GLP‐1 is a coronary artery vasodilator in humans SJ Clarke, JP Giblett, LL Yang, A Hubsch, T Zhao, ... Journal of the American Heart Association 7 (22), e010321, 2018 | 16 | 2018 |
Rapid Pacing–Induced Right Ventricular Dysfunction Is Evident After Balloon-Expandable Transfemoral Aortic Valve Replacement RG Axell, PA White, JP Giblett, L Williams, BS Rana, A Klein, M O’Sullivan, ... Journal of the American College of Cardiology 69 (7), 903-904, 2017 | 15 | 2017 |
Cardioprotection for percutaneous coronary intervention—reperfusion quality as well as quantity JP Giblett, NEJ West, SP Hoole International journal of cardiology 177 (3), 786-793, 2014 | 15 | 2014 |
Anatomical plaque and vessel characteristics are associated with hemodynamic indices including fractional flow reserve and coronary flow reserve: A prospective exploratory … AJ Brown, JP Giblett, MR Bennett, NEJ West, SP Hoole International Journal of Cardiology 248, 92-96, 2017 | 14 | 2017 |
Stunning and right ventricular dysfunction is induced by coronary balloon occlusion and rapid pacing in humans: insights from right ventricular conductance catheter studies RG Axell, JP Giblett, PA White, A Klein, J Hampton‐Til, M O'Sullivan, ... Journal of the American Heart Association 6 (6), e005820, 2017 | 14 | 2017 |
Implantation of bioresorbable vascular scaffolds following acute coronary syndrome is associated with reduced early neointimal growth and strut coverage JP Giblett, AJ Brown, H Keevil, C Jaworski, SP Hoole, NE West EuroIntervention 12 (6), 724-733, 2016 | 14 | 2016 |
Remote ischemic conditioning in elective PCI? JP Giblett, SP Hoole Journal of cardiovascular pharmacology and therapeutics 22 (4), 310-315, 2017 | 10 | 2017 |
Adenosine‐Induced Coronary Steal Is Observed in Patients Presenting With ST‐Segment–Elevation Myocardial Infarction M Aetesam‐ur‐Rahman, AJ Brown, C Jaworski, JP Giblett, TX Zhao, ... Journal of the American Heart Association 10 (13), e019899, 2021 | 9 | 2021 |
Cardioprotection for acute MI in light of the CONDI2/ERIC-PPCI trial: new targets needed JP Giblett, H Bulluck Interventional Cardiology Review 15, 2020 | 8 | 2020 |
Comparison of routine versus selective glycoprotein IIb/IIIa inhibitors usage in primary percutaneous coronary intervention (from the British Cardiovascular Interventional Society) M Orzalkiewicz, J Hodson, CS Kwok, PF Ludman, JP Giblett, S George, ... The American journal of cardiology 124 (3), 373-380, 2019 | 8 | 2019 |